Skip to main content
Top
Published in: Annals of Surgical Oncology 1/2016

01-01-2016 | Urologic Oncology

The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy

Authors: Minyong Kang, MD, PhD, Chang Wook Jeong, MD, PhD, Cheol Kwak, MD, PhD, Hyeon Hoe Kim, MD, PhD, Ja Hyeon Ku, MD, PhD

Published in: Annals of Surgical Oncology | Issue 1/2016

Login to get access

Abstract

Purpose

Because the pretreatment neutrophil-to-lymphocyte ratio (NLR) is a reliable prognostic factor, the authors of this study hypothesized that posttreatment NLR also predicts the survival outcome for cancer patients. The study investigated the clinicopathologic features according to postoperative NLR and determined the prognostic significance of early postoperative NLR for bladder cancer patients undergoing radical cystectomy (RC).

Methods

The study reviewed 385 bladder cancer patients treated with RC and pelvic lymph node dissection at the authors’ institution between 1999 and 2012. The primary end points of the study were cancer-specific survival (CSS) and overall survival (OS) estimates from the Kaplan–Meier analysis. Multivariate Cox regression analysis was adopted to identify the independent prognostic factors for oncologic outcomes after surgery.

Results

Patients with elevated postoperative NLR (≥2.0) had higher rates of advanced pathologic tumor stage (≥pT3), lymphovascular invasion, and lymph node involvement. Notably, they showed poorer CSS and OS rates than patients with a postoperative NLR lower than 2.0. Additionally, patients with pre- and postoperative elevated NLR (≥2.1 → ≥2.0) demonstrated worse oncologic outcomes than other groups of NLR changes. Multivariate analysis showed that early postoperative NLR remained a key predictor for CSS and OS. When divided by pathologic T or N stage, patients with localized pathologic T stage or pN0 status showed significant differences in survival according to early postoperative NLR.

Conclusion

In summary, postoperative NLR in the early recovery period can be a valuable biomarker for predicting oncologic outcomes for bladder cancer patients undergoing RC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stamatakis L, Godoy G, Lerner SP. Innovations in radical cystectomy and pelvic lymph node dissection. Semin Oncol. 2012;39:573–82.PubMedCrossRef Stamatakis L, Godoy G, Lerner SP. Innovations in radical cystectomy and pelvic lymph node dissection. Semin Oncol. 2012;39:573–82.PubMedCrossRef
2.
go back to reference Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol. 2001;19:666–75.PubMed Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol. 2001;19:666–75.PubMed
3.
go back to reference Smith ZL, Christodouleas JP, Keefe SM, Malkowicz SB, Guzzo TJ. Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy. BJU Int. 2013;112:13–25.PubMedCrossRef Smith ZL, Christodouleas JP, Keefe SM, Malkowicz SB, Guzzo TJ. Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy. BJU Int. 2013;112:13–25.PubMedCrossRef
4.
go back to reference Witjes JA, Comperat E, Cowan NC, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65:778–92.PubMedCrossRef Witjes JA, Comperat E, Cowan NC, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65:778–92.PubMedCrossRef
5.
go back to reference Prasad SM, Decastro GJ, Steinberg GD. Urothelial carcinoma of the bladder: definition, treatment, and future efforts. Nat Rev Urol. 2011;8:631–42.PubMedCrossRef Prasad SM, Decastro GJ, Steinberg GD. Urothelial carcinoma of the bladder: definition, treatment, and future efforts. Nat Rev Urol. 2011;8:631–42.PubMedCrossRef
6.
7.
go back to reference Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493–503.PubMedCrossRef Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493–503.PubMedCrossRef
8.
go back to reference Kim YW, Kim SK, Kim CS, Kim IY, Cho MY, Kim NK. Association of serum and intratumoral cytokine profiles with tumor stage and neutrophil lymphocyte ratio in colorectal cancer. Anticancer Res. 2014;34:3481–7.PubMed Kim YW, Kim SK, Kim CS, Kim IY, Cho MY, Kim NK. Association of serum and intratumoral cytokine profiles with tumor stage and neutrophil lymphocyte ratio in colorectal cancer. Anticancer Res. 2014;34:3481–7.PubMed
9.
go back to reference Burke RM, Madden KS, Perry SW, Zettel ML, Brown EB III. Tumor-associated macrophages and stromal TNF-alpha regulate collagen structure in a breast tumor model as visualized by second harmonic generation. J Biomed Opt. 2013;18:86003.PubMedCrossRef Burke RM, Madden KS, Perry SW, Zettel ML, Brown EB III. Tumor-associated macrophages and stromal TNF-alpha regulate collagen structure in a breast tumor model as visualized by second harmonic generation. J Biomed Opt. 2013;18:86003.PubMedCrossRef
10.
go back to reference Li MX, Liu XM, Zhang XF, et al. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2014;134:2403–13.PubMedCrossRef Li MX, Liu XM, Zhang XF, et al. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2014;134:2403–13.PubMedCrossRef
11.
go back to reference Gondo T, Nakashima J, Ohno Y, et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology. 2012;79:1085–91.PubMedCrossRef Gondo T, Nakashima J, Ohno Y, et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology. 2012;79:1085–91.PubMedCrossRef
12.
go back to reference Viers BR, Boorjian SA, Frank I, et al. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Eur Urol. 2014;66:1157–64.PubMedCrossRef Viers BR, Boorjian SA, Frank I, et al. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Eur Urol. 2014;66:1157–64.PubMedCrossRef
13.
go back to reference Hermanns T, Bhindi B, Wei Y, et al. Pretreatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Br J Cancer. 2014;111:444–51.PubMedPubMedCentralCrossRef Hermanns T, Bhindi B, Wei Y, et al. Pretreatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Br J Cancer. 2014;111:444–51.PubMedPubMedCentralCrossRef
14.
go back to reference Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu L, Chen M. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PloS One. 2013;8:e58184.PubMedPubMedCentralCrossRef Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu L, Chen M. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PloS One. 2013;8:e58184.PubMedPubMedCentralCrossRef
15.
go back to reference Peng W, Li C, Wen TF, et al. Neutrophil-to-lymphocyte ratio changes predict small hepatocellular carcinoma survival. J Surg Res. 2014;192:402–8.PubMedCrossRef Peng W, Li C, Wen TF, et al. Neutrophil-to-lymphocyte ratio changes predict small hepatocellular carcinoma survival. J Surg Res. 2014;192:402–8.PubMedCrossRef
16.
go back to reference Moon KC, Kim M, Kwak C, Kim HH, Ku JH. External validation of online predictive models for prediction of cancer-specific mortality and all-cause mortality in patients with urothelial carcinoma of the urinary bladder. Ann Surg Oncol. 2014;21:3132–41.PubMedCrossRef Moon KC, Kim M, Kwak C, Kim HH, Ku JH. External validation of online predictive models for prediction of cancer-specific mortality and all-cause mortality in patients with urothelial carcinoma of the urinary bladder. Ann Surg Oncol. 2014;21:3132–41.PubMedCrossRef
17.
go back to reference Azuma T, Matayoshi Y, Odani K, Sato Y, Sato Y, Nagase Y, Oshi M. Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma. Clin Genitourin Cancer. 2013;11:337–41.PubMedCrossRef Azuma T, Matayoshi Y, Odani K, Sato Y, Sato Y, Nagase Y, Oshi M. Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma. Clin Genitourin Cancer. 2013;11:337–41.PubMedCrossRef
18.
go back to reference Pichler M, Hutterer GC, Stoeckigt C, et al. Validation of the pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer. 2013;108:901–7.PubMedPubMedCentralCrossRef Pichler M, Hutterer GC, Stoeckigt C, et al. Validation of the pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer. 2013;108:901–7.PubMedPubMedCentralCrossRef
19.
go back to reference Park YH, Ku JH, Kwak C, Kim HH. Posttreatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first-line therapy. Springerplus. 2014;3:243.PubMedPubMedCentralCrossRef Park YH, Ku JH, Kwak C, Kim HH. Posttreatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first-line therapy. Springerplus. 2014;3:243.PubMedPubMedCentralCrossRef
21.
go back to reference Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, Hirakawa K. A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer. Anticancer Res. 2013;33:3291–4.PubMed Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, Hirakawa K. A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer. Anticancer Res. 2013;33:3291–4.PubMed
22.
go back to reference Liao W, Zhang J, Zhu Q, et al. Preoperative neutrophil-to-lymphocyte ratio as a new prognostic marker in hepatocellular carcinoma after curative resection. Transl Oncol. 2014;7:248–55.PubMedPubMedCentralCrossRef Liao W, Zhang J, Zhu Q, et al. Preoperative neutrophil-to-lymphocyte ratio as a new prognostic marker in hepatocellular carcinoma after curative resection. Transl Oncol. 2014;7:248–55.PubMedPubMedCentralCrossRef
23.
go back to reference de Martino M, Pantuck AJ, Hofbauer S, Waldert M, Shariat SF, Belldegrun AS, Klatte T. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. J Urol. 2013;190:1999–2004.PubMedCrossRef de Martino M, Pantuck AJ, Hofbauer S, Waldert M, Shariat SF, Belldegrun AS, Klatte T. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. J Urol. 2013;190:1999–2004.PubMedCrossRef
24.
go back to reference Ceylan C, Doluoglu OG, Keles I, Gazel E, Temuçin T, Odabaş Ö, Karalar M. Importance of the neutrophil-to-lymphocyte ratio in muscle-invasive and non–muscle-invasive bladder tumors. Urologia. 2014;81:120–4.PubMedCrossRef Ceylan C, Doluoglu OG, Keles I, Gazel E, Temuçin T, Odabaş Ö, Karalar M. Importance of the neutrophil-to-lymphocyte ratio in muscle-invasive and non–muscle-invasive bladder tumors. Urologia. 2014;81:120–4.PubMedCrossRef
25.
go back to reference Ku JH, Kang M, Kim HS, Jeong CW, Kwak C, Kim HH. The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy. Br J Cancer. 2015;112:461–7.PubMedCrossRef Ku JH, Kang M, Kim HS, Jeong CW, Kwak C, Kim HH. The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy. Br J Cancer. 2015;112:461–7.PubMedCrossRef
26.
go back to reference An X, Ding PR, Li YH, et al. Elevated neutrophil-to-lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers. 2010;15:516–22.PubMedCrossRef An X, Ding PR, Li YH, et al. Elevated neutrophil-to-lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers. 2010;15:516–22.PubMedCrossRef
27.
go back to reference De Larco JE, Wuertz BR, Furcht LT. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res. 2004;10:4895–900.PubMedCrossRef De Larco JE, Wuertz BR, Furcht LT. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res. 2004;10:4895–900.PubMedCrossRef
28.
29.
go back to reference Langsenlehner T, Thurner EM, Krenn-Pilko S, Langsenlehner U, Stojakovic T, Gerger A, Pichler M. Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients. World J Urol. 2015. doi:10.1007/s00345-015-1494-7. Langsenlehner T, Thurner EM, Krenn-Pilko S, Langsenlehner U, Stojakovic T, Gerger A, Pichler M. Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients. World J Urol. 2015. doi:10.​1007/​s00345-015-1494-7.
30.
go back to reference Krane LS, Richards KA, Kader AK, Davis R, Balaji KC, Hemal AK. Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. J Endourol. 2013;27:1046–50.PubMedCrossRef Krane LS, Richards KA, Kader AK, Davis R, Balaji KC, Hemal AK. Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. J Endourol. 2013;27:1046–50.PubMedCrossRef
Metadata
Title
The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy
Authors
Minyong Kang, MD, PhD
Chang Wook Jeong, MD, PhD
Cheol Kwak, MD, PhD
Hyeon Hoe Kim, MD, PhD
Ja Hyeon Ku, MD, PhD
Publication date
01-01-2016
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 1/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4708-8

Other articles of this Issue 1/2016

Annals of Surgical Oncology 1/2016 Go to the issue